MACROGENICS INC

Profile

Company Names

MACROGENICS INC

Addresses

1500 EAST GUDE DRIVE, ROCKVILLE, MD 20850

Phone Numbers

301-251-5172

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,016,500.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-01-19 
$12,016,500.00 
$12,016,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAULO 
 
COSTA 
DIRECTOR
MACROGENICS INC
KEN 
 
GALBRAITH 
DIRECTOR
MACROGENICS INC
ED 
 
HURWITZ 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  SUNESIS PHARMACEUTICALS INC   |  TALIGEN THERAPEUTICS INC   |  CARA THERAPEUTICS INC   |  MACROGENICS INC   |  VIEWPOINT THERAPEUTICS, INC.   |  REKINDLE THERAPEUTICS INC.   |  BIOINTERVENE, INC.   |  ARIALYS THERAPEUTICS, INC.
JAMES 
 
KARRELS 
EXECUTIVE OFFICER
MACROGENICS INC
SCOTT 
 
KOENIG 
EXECUTIVE OFFICER, DIRECTOR
APPLIED GENETIC TECHNOLOGIES CORP   |  MACROGENICS INC   |  NB REAL ESTATE SECONDARY OPPORTUNITIES FUND LP   |  NB REAL ESTATE SECONDARY OPPORTUNITIES OFFSHORE FUND LP   |  NB STRATEGIC CAPITAL LP   |  NB STRATEGIC CAPITAL OFFSHORE LP   |  NB SECONDARY OPPORTUNITIES FUND V LP   |  NB SECONDARY OPPORTUNITIES OFFSHORE FUND V LP   |  NB STRATEGIC CAPITAL OFFSHORE II LP   |  NB STRATEGIC CAPITAL II LP   |  NB REAL ESTATE SECONDARY OPPORTUNITIES OFFSHORE FUND II LP   |  NB REAL ESTATE SECONDARY OPPORTUNITIES FUND II LP   |  NB STRATEGIC CAPITAL OFFSHORE EU II SCSP   |  NB STRATEGIC CAPITAL II CO-INVEST LP
ARNOLD 
 
ORONSKY 
DIRECTOR
APPLIED GENETIC TECHNOLOGIES CORP   |  ARCION THEREAPEUTICS INC   |  DRAIS PHARMACEUTICALS INC   |  ARCION THERAPEUTICS, INC.   |  USDS, INC.   |  MACROGENICS INC   |  TESARO, INC.   |  TELSAR PHARMA, INC.   |  SELDAR PHARMA, INC.   |  INTEGRATED DIAGNOSTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  PMV PHARMACEUTICALS, INC.   |  CENTREXION THERAPEUTICS CORP
PAUL 
 
SEKHRI 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  MACROGENICS INC   |  PATIENTSAFE SOLUTIONS, INC.   |  TANDEM DIABETES CARE INC   |  LYCERA CORP   |  PETRA PHARMA CORP   |  LIKEMINDS, INC./DE   |  COMPUGEN LTD   |  ALPINE IMMUNE SCIENCES, INC.   |  EGENESIS, INC.   |  ADITUM BIO FUND 1, L.P.   |  BIOMX INC.   |  AXCELLA HEALTH INC.
MICHAEL 
 
STEINMETZ 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  MACROGENICS INC   |  ALLOZYNE INC   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  LYCERA CORP   |  VBI VACCINES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#